triiodothyronine has been researched along with Stroke in 33 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Low triiodothyronine (T3) syndrome could be a powerful prognostic factor for acute stroke; yet, a prognostic role for low T3 has not been given enough importance in stroke management." | 8.98 | A prognostic role for Low tri-iodothyronine syndrome in acute stroke patients: A systematic review and meta-analysis. ( Broekman, MLD; Bunevicius, A; Doucette, J; Lamba, N; Liu, C; Mekary, RA; Ren, S; Shi, C; Simjian, T; Smith, TR; Zaidi, H, 2018) |
| "Patients with acute ischemic stroke (AIS) often experience low serum free triiodothyronine (FT3), but the association of low FT3 with stroke severity, subtype and prognosis has not yet been thoroughly studied, and the molecular events underlying these clinical observation were also unclear." | 7.91 | Low free triiodothyronineis predicts worsen neurological outcome of patients with acute ischemic stroke: a retrospective study with bioinformatics analysis. ( Qiao, S; Si, Z; Wang, A; Xu, S; Xu, X; Yang, Y; Yuan, J; Zhang, S; Zhao, X, 2019) |
| "It is uncertain that the effect of free triiodothyronine (FT3) within normal ranges on initial severity and early functional outcomes in acute ischemic stroke (AIS) patients with Intracranial Atherosclerotic Stenosis (ICAS)." | 7.91 | Low-normal free triiodothyronine and high leukocyte levels in relation to stroke severity and poor outcome in acute ischemic stroke with intracranial atherosclerotic stenosis. ( Feng, X; Li, Z; Liu, Y; Liu, Z; Wang, J; Xia, J; Yang, Q; Yu, F; Zhan, Q; Zhou, X, 2019) |
| "Patients with acute ischemic stroke (AIS) frequently experience low free triiodothyronine (fT3) concentrations." | 7.83 | Low triiodothyronine: A new facet of inflammation in acute ischemic stroke. ( Chen, X; Jiang, Y; Liu, M; Liu, Y; Ma, L; Ma, X; Zhu, D, 2016) |
| "Low free triiodothyronine (fT3) levels have been associated with increased mortality and poor functional outcomes in patients with stroke." | 7.83 | Low free triiodothyronine levels are related to symptomatic intracranial hemorrhage and poor functional outcomes after intravenous thrombolysis in acute ischemic stroke patients. ( Liu, J; Liu, M; Tao, W; Wang, D; Xiong, Y; Yuan, R, 2016) |
| "Elevated concentrations of C-reactive protein (CRP) and decreased concentrations of triiodothyronine (T3) were shown to predict poor outcomes in patients with stroke." | 7.80 | Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study. ( Bunevicius, A; Bunevicius, R; Janusonis, V; Kazlauskas, H; Raskauskiene, N, 2014) |
| "SAP in individuals with low T3 syndrome was substantially greater (p < ." | 5.72 | Low triiodothyronine syndrome is associated with stroke-associated pneumonia. ( Chen, H; He, J; Huang, Y; Ren, W; Xu, M, 2022) |
| "Low triiodothyronine (T3) has been associated with increased short-term mortality in intensive care unit patients and long-term mortality in patients with heart disease." | 5.34 | Low triiodothyronine: a strong predictor of outcome in acute stroke patients. ( Alevizaki, M; Pappa, T; Synetou, M; Vemmos, KN; Xynos, K, 2007) |
| "Low triiodothyronine (T3) syndrome could be a powerful prognostic factor for acute stroke; yet, a prognostic role for low T3 has not been given enough importance in stroke management." | 4.98 | A prognostic role for Low tri-iodothyronine syndrome in acute stroke patients: A systematic review and meta-analysis. ( Broekman, MLD; Bunevicius, A; Doucette, J; Lamba, N; Liu, C; Mekary, RA; Ren, S; Shi, C; Simjian, T; Smith, TR; Zaidi, H, 2018) |
| "Patients with acute ischemic stroke (AIS) often experience low serum free triiodothyronine (FT3), but the association of low FT3 with stroke severity, subtype and prognosis has not yet been thoroughly studied, and the molecular events underlying these clinical observation were also unclear." | 3.91 | Low free triiodothyronineis predicts worsen neurological outcome of patients with acute ischemic stroke: a retrospective study with bioinformatics analysis. ( Qiao, S; Si, Z; Wang, A; Xu, S; Xu, X; Yang, Y; Yuan, J; Zhang, S; Zhao, X, 2019) |
| "It is uncertain that the effect of free triiodothyronine (FT3) within normal ranges on initial severity and early functional outcomes in acute ischemic stroke (AIS) patients with Intracranial Atherosclerotic Stenosis (ICAS)." | 3.91 | Low-normal free triiodothyronine and high leukocyte levels in relation to stroke severity and poor outcome in acute ischemic stroke with intracranial atherosclerotic stenosis. ( Feng, X; Li, Z; Liu, Y; Liu, Z; Wang, J; Xia, J; Yang, Q; Yu, F; Zhan, Q; Zhou, X, 2019) |
| "Serum triiodothyronine (T3) concentration was reported to be associated with the prognosis after acute ischemic stroke." | 3.91 | The prognostic value of total T3 after acute cerebral infarction is age-dependent: a retrospective study on 768 patients. ( Hu, XY; Li, LQ; Li, WY; Lv, W; Xu, XY, 2019) |
| "Several studies have shown that high level of plasma C-reactive protein (CRP) is associated with stroke outcomes and future vascular events, and a decrease in serum triiodothyronine (T3) was reported to be associated with stroke severity and poor prognosis." | 3.88 | C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic Stroke. ( Ifteni, PI; Irimie, CA; Irimie, M; Minea, DI; Vârciu, M, 2018) |
| "Low serum triiodothyronine levels can be a predictive marker of short-term outcome after ischemic stroke." | 3.85 | Low T ( Bao, J; Pan, S; Wang, Y; Zhang, X; Zhou, S, 2017) |
| "Patients with acute ischemic stroke (AIS) frequently experience low free triiodothyronine (fT3) concentrations." | 3.83 | Low triiodothyronine: A new facet of inflammation in acute ischemic stroke. ( Chen, X; Jiang, Y; Liu, M; Liu, Y; Ma, L; Ma, X; Zhu, D, 2016) |
| "Low free triiodothyronine (fT3) levels have been associated with increased mortality and poor functional outcomes in patients with stroke." | 3.83 | Low free triiodothyronine levels are related to symptomatic intracranial hemorrhage and poor functional outcomes after intravenous thrombolysis in acute ischemic stroke patients. ( Liu, J; Liu, M; Tao, W; Wang, D; Xiong, Y; Yuan, R, 2016) |
| "Elevated concentrations of C-reactive protein (CRP) and decreased concentrations of triiodothyronine (T3) were shown to predict poor outcomes in patients with stroke." | 3.80 | Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study. ( Bunevicius, A; Bunevicius, R; Janusonis, V; Kazlauskas, H; Raskauskiene, N, 2014) |
| "In the present study, nonthyroidal illness syndrome (NTIS), which is characterized by reduction of serum triiodothyronine (T3) without elevation of thyroid-stimulating hormone (TSH), was induced by protein-energy malnutrition (PCM)." | 3.73 | Malnutrition and nonthyroidal illness syndrome after stroke. ( Arita, K; Hama, S; Imura, I; Kitaoka, T; Kurisu, K; Seno, H; Shigenobu, M; Tominaga, A; Watanabe, A, 2005) |
| "Stroke is the fifth leading cause of mortality in the United States and a leading cause of disability." | 2.55 | Ischemic Stroke and Impact of Thyroid Profile at Presentation: A Systematic Review and Meta-analysis of Observational Studies. ( Basnet, S; Dhital, R; Gyawali, B; Karmacharya, P; Poudel, DR; Shrestha, P; Tachamo, N, 2017) |
| "SAP in individuals with low T3 syndrome was substantially greater (p < ." | 1.72 | Low triiodothyronine syndrome is associated with stroke-associated pneumonia. ( Chen, H; He, J; Huang, Y; Ren, W; Xu, M, 2022) |
| " This study was designed to evaluate the effects of retinoic acid (RA)-pretreated Wharton's jelly mesenchymal stem cells (WJ-MSCs) in combination with triiodothyronine (T3) in the ischemia stroke model." | 1.46 | Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury. ( Akbari, M; Ataeinejad, N; Hassanzadeh, G; Kashani, IR; Moini, A; Mortezaee, K; Sabbaghziarani, F; Soleimani, M; Zendedel, A, 2017) |
| "Ischemic stroke is a common leading cause of death and disability with lack of effective therapies." | 1.46 | Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region. ( Akbari, M; Attari, F; Ghazi-Khansari, M; Hassanzadeh, G; Kashani, IR; Malek, F; Mokhtari, T; Noorbakhsh, F; Rastegar, T, 2017) |
| "We have used both transient middle cerebral artery occlusion (t-MCAO) and permanent (p-MCAO) models of ischemic brain stroke." | 1.42 | Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: Possible association with AQP4 modulation. ( Burke, J; Coughlin, L; Mdzinarishvili, A; Sadana, P; Woods, R, 2015) |
| "Thyroid storm is a rare disorder with a sudden onset, rapid progression and high mortality." | 1.38 | Thyroid storm with multiple organ failure, disseminated intravascular coagulation, and stroke with a normal serum FT3 level. ( Akiyama, H; Handa, M; Harada, Y; Ryuzaki, M; Urao, Y; Yoshimoto, T, 2012) |
| "Low triiodothyronine (T3) has been associated with increased short-term mortality in intensive care unit patients and long-term mortality in patients with heart disease." | 1.34 | Low triiodothyronine: a strong predictor of outcome in acute stroke patients. ( Alevizaki, M; Pappa, T; Synetou, M; Vemmos, KN; Xynos, K, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (12.12) | 29.6817 |
| 2010's | 26 (78.79) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Song, Y | 1 |
| Yang, C | 1 |
| Wang, H | 1 |
| Chen, H | 2 |
| Xu, M | 1 |
| Huang, Y | 1 |
| He, J | 2 |
| Ren, W | 1 |
| Feng, Q | 1 |
| Li, Y | 1 |
| Zhu, Y | 1 |
| Xia, Y | 1 |
| Zhang, T | 1 |
| Hu, M | 1 |
| Li, W | 1 |
| Wu, M | 1 |
| Zhang, S | 1 |
| Zhao, X | 1 |
| Xu, S | 1 |
| Yuan, J | 1 |
| Si, Z | 1 |
| Yang, Y | 1 |
| Qiao, S | 1 |
| Xu, X | 1 |
| Wang, A | 1 |
| Dhital, R | 1 |
| Poudel, DR | 1 |
| Tachamo, N | 1 |
| Gyawali, B | 1 |
| Basnet, S | 1 |
| Shrestha, P | 1 |
| Karmacharya, P | 1 |
| Boltzmann, M | 1 |
| Schmidt, SB | 1 |
| Rollnik, JD | 1 |
| Suda, S | 3 |
| Aoki, J | 3 |
| Shimoyama, T | 3 |
| Suzuki, K | 3 |
| Sakamoto, Y | 3 |
| Katano, T | 1 |
| Okubo, S | 2 |
| Nito, C | 3 |
| Nishiyama, Y | 2 |
| Mishina, M | 2 |
| Kimura, K | 3 |
| Qiu, M | 1 |
| Fang, M | 1 |
| Liu, X | 1 |
| Zhou, X | 2 |
| Yu, F | 2 |
| Feng, X | 2 |
| Wang, J | 2 |
| Li, Z | 2 |
| Zhan, Q | 2 |
| Xia, J | 2 |
| Lamba, N | 1 |
| Liu, C | 1 |
| Zaidi, H | 1 |
| Broekman, MLD | 1 |
| Simjian, T | 1 |
| Shi, C | 1 |
| Doucette, J | 1 |
| Ren, S | 1 |
| Smith, TR | 1 |
| Mekary, RA | 1 |
| Bunevicius, A | 2 |
| Irimie, CA | 1 |
| Vârciu, M | 1 |
| Irimie, M | 1 |
| Ifteni, PI | 1 |
| Minea, DI | 1 |
| Nagai, K | 1 |
| Arakawa, M | 1 |
| Kanamaru, T | 2 |
| Takeshi, Y | 1 |
| Matsumoto, N | 1 |
| Wu, Y | 1 |
| Huang, G | 1 |
| He, W | 1 |
| Lin, S | 1 |
| Zhang, X | 2 |
| Liu, Z | 1 |
| Yang, Q | 1 |
| Liu, Y | 2 |
| Li, LQ | 1 |
| Xu, XY | 1 |
| Li, WY | 1 |
| Hu, XY | 1 |
| Lv, W | 1 |
| Taroza, S | 1 |
| Rastenytė, D | 1 |
| Burkauskas, J | 1 |
| Podlipskytė, A | 1 |
| Mickuvienė, N | 1 |
| Kazlauskas, H | 1 |
| Raskauskiene, N | 1 |
| Janusonis, V | 1 |
| Bunevicius, R | 1 |
| Sadana, P | 1 |
| Coughlin, L | 1 |
| Burke, J | 1 |
| Woods, R | 1 |
| Mdzinarishvili, A | 1 |
| Sayre, NL | 1 |
| Sifuentes, M | 1 |
| Holstein, D | 1 |
| Cheng, SY | 1 |
| Zhu, X | 1 |
| Lechleiter, JD | 1 |
| Ma, L | 1 |
| Zhu, D | 1 |
| Jiang, Y | 1 |
| Ma, X | 1 |
| Liu, M | 2 |
| Chen, X | 1 |
| Liu, J | 1 |
| Wang, D | 1 |
| Xiong, Y | 1 |
| Yuan, R | 1 |
| Tao, W | 1 |
| Wang, Y | 1 |
| Zhou, S | 1 |
| Bao, J | 1 |
| Pan, S | 1 |
| Muraga, K | 1 |
| Abe, A | 1 |
| Sabbaghziarani, F | 1 |
| Mortezaee, K | 1 |
| Akbari, M | 2 |
| Kashani, IR | 2 |
| Soleimani, M | 1 |
| Moini, A | 1 |
| Ataeinejad, N | 1 |
| Zendedel, A | 1 |
| Hassanzadeh, G | 2 |
| Skalny, AV | 1 |
| Klimenko, LL | 1 |
| Turna, AA | 1 |
| Budanova, MN | 1 |
| Baskakov, IS | 1 |
| Savostina, MS | 1 |
| Mazilina, AN | 1 |
| Deyev, AI | 1 |
| Skalnaya, MG | 1 |
| Tinkov, AA | 1 |
| Mokhtari, T | 1 |
| Malek, F | 1 |
| Rastegar, T | 1 |
| Noorbakhsh, F | 1 |
| Ghazi-Khansari, M | 1 |
| Attari, F | 1 |
| Ambrosius, W | 1 |
| Kazmierski, R | 1 |
| Gupta, V | 1 |
| Warot, AW | 1 |
| Adamczewska-Kociałkowska, D | 1 |
| Błazejewska, A | 1 |
| Ziemnicka, K | 1 |
| Nowinski, WL | 1 |
| Neidert, S | 1 |
| Katan, M | 1 |
| Schuetz, P | 1 |
| Fluri, F | 1 |
| Ernst, A | 1 |
| Bingisser, R | 1 |
| Kappos, L | 1 |
| Engelter, ST | 1 |
| Steck, A | 1 |
| Müller, B | 1 |
| Christ-Crain, M | 1 |
| Harada, Y | 1 |
| Akiyama, H | 1 |
| Yoshimoto, T | 1 |
| Urao, Y | 1 |
| Ryuzaki, M | 1 |
| Handa, M | 1 |
| Huang, JS | 1 |
| Bai, JC | 1 |
| Huang, GL | 1 |
| Hama, S | 1 |
| Kitaoka, T | 1 |
| Shigenobu, M | 1 |
| Watanabe, A | 1 |
| Imura, I | 1 |
| Seno, H | 1 |
| Tominaga, A | 1 |
| Arita, K | 1 |
| Kurisu, K | 1 |
| Alevizaki, M | 2 |
| Synetou, M | 2 |
| Xynos, K | 2 |
| Alevizaki, CC | 1 |
| Vemmos, KN | 2 |
| Pappa, T | 1 |
2 reviews available for triiodothyronine and Stroke
| Article | Year |
|---|---|
Ischemic Stroke and Impact of Thyroid Profile at Presentation: A Systematic Review and Meta-analysis of Observational Studies.
Topics: Asymptomatic Diseases; Biomarkers; Brain Ischemia; Chi-Square Distribution; Humans; Hyperthyroidism; | 2017 |
A prognostic role for Low tri-iodothyronine syndrome in acute stroke patients: A systematic review and meta-analysis.
Topics: Biomarkers; Cohort Studies; Humans; Mortality; Prognosis; Stroke; Syndrome; Triiodothyronine | 2018 |
31 other studies available for triiodothyronine and Stroke
| Article | Year |
|---|---|
Free Triiodothyronine Is Associated with Poor Outcomes after Acute Ischemic Stroke.
Topics: Humans; Ischemic Stroke; Stroke; Thyroid Function Tests; Thyroid Hormones; Triiodothyronine; United | 2022 |
Low triiodothyronine syndrome is associated with stroke-associated pneumonia.
Topics: Brain Ischemia; Euthyroid Sick Syndromes; Humans; Pneumonia; Stroke; Thyrotropin; Triiodothyronine | 2022 |
Admission thyroid function in relation to 90-day outcome of acute ischemic stroke.
Topics: Humans; Ischemic Stroke; Stroke; Thyrotropin; Thyroxine; Triiodothyronine | 2023 |
Low free triiodothyronineis predicts worsen neurological outcome of patients with acute ischemic stroke: a retrospective study with bioinformatics analysis.
Topics: Computational Biology; Humans; Prognosis; Retrospective Studies; Stroke; Triiodothyronine | 2019 |
Impact of Thyroid Hormone Levels on Functional Outcome in Neurological and Neurosurgical Early Rehabilitation Patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Glasgow Coma Scale; Humans; Male; Middle Aged; N | 2017 |
Low Free Triiodothyronine at Admission Predicts Poststroke Infection.
Topics: Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Female; Humans; Japan; Logistic Models | 2018 |
Low free triiodothyronine levels predict symptomatic intracranial hemorrhage and worse short-term outcome of thrombolysis in patients with acute ischemia stroke.
Topics: Age Factors; Aged; Body Mass Index; Comorbidity; Female; Fibrinolytic Agents; Humans; Intracranial H | 2017 |
Immunity and inflammation predictors for short-term outcome of stroke in young adults.
Topics: Adolescent; Adult; Blood Glucose; Female; Globulins; Humans; Immunity; Inflammation; Leukocyte Count | 2018 |
C-Reactive Protein and T3: New Prognostic Factors in Acute Ischemic Stroke.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; C-Reactive Protein; Cognition; Disability Evalu | 2018 |
Low Free Triiodothyronine Predicts 3-Month Poor Outcome After Acute Stroke.
Topics: Aged; Aged, 80 and over; Biomarkers; Chi-Square Distribution; Comorbidity; Disability Evaluation; Do | 2018 |
Low Tri-iodothyronine Syndrome Is Associated With Cognitive Impairment in Patients With Acute Ischemic Stroke: A Prospective Cohort Study.
Topics: Adult; Brain Ischemia; Cognitive Dysfunction; Female; Follow-Up Studies; Humans; Hypothyroidism; Mal | 2018 |
Low-normal free triiodothyronine and high leukocyte levels in relation to stroke severity and poor outcome in acute ischemic stroke with intracranial atherosclerotic stenosis.
Topics: Brain Ischemia; Female; Humans; Intracranial Arteriosclerosis; Leukocyte Count; Male; Middle Aged; R | 2019 |
The prognostic value of total T3 after acute cerebral infarction is age-dependent: a retrospective study on 768 patients.
Topics: Age Factors; Aged; Biomarkers; Brain Ischemia; Female; Humans; Male; Middle Aged; Odds Ratio; Progno | 2019 |
Lower serum free triiodothyronine levels are associated with symptoms of depression after ischemic stroke.
Topics: Aged; Depression; Female; Humans; Male; Middle Aged; Risk Factors; Stroke; Triiodothyronine | 2019 |
Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study.
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cognition Disorders; Female; Humans; Male; | 2014 |
Anti-edema action of thyroid hormone in MCAO model of ischemic brain stroke: Possible association with AQP4 modulation.
Topics: Animals; Aquaporin 4; Brain Edema; Cerebrovascular Circulation; Diiodothyronines; Infarction, Middle | 2015 |
Stimulation of astrocyte fatty acid oxidation by thyroid hormone is protective against ischemic stroke-induced damage.
Topics: Adenosine Triphosphate; Animals; Astrocytes; Brain Ischemia; Cell Survival; Cells, Cultured; Fatty A | 2017 |
Low triiodothyronine: A new facet of inflammation in acute ischemic stroke.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Humans; Inflammation; Male; Middle Aged; Str | 2016 |
Low free triiodothyronine levels are related to symptomatic intracranial hemorrhage and poor functional outcomes after intravenous thrombolysis in acute ischemic stroke patients.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Injections, Intravenou | 2016 |
Low T
Topics: Aged; Biomarkers; Brain Ischemia; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Asse | 2017 |
Low free triiodothyronine predicts poor functional outcome after acute ischemic stroke.
Topics: Aged; Biomarkers; Brain; Brain Ischemia; Female; Hospitalization; Humans; Logistic Models; Male; Pro | 2016 |
Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cytokines; Disease Models, Animal; Infarction, Middle Ce | 2017 |
Serum trace elements are interrelated with hormonal imbalance in men with acute ischemic stroke.
Topics: Aged; Brain Ischemia; Estradiol; Humans; Iodine; Male; Middle Aged; Progesterone; Stroke; Testostero | 2017 |
Improvement of memory and learning by intracerebroventricular microinjection of T3 in rat model of ischemic brain stroke mediated by upregulation of BDNF and GDNF in CA1 hippocampal region.
Topics: Animals; Behavior, Animal; Body Weight; Brain-Derived Neurotrophic Factor; CA1 Region, Hippocampal; | 2017 |
Low free triiodothyronine levels are related to poor prognosis in acute ischemic stroke.
Topics: Aged; Aged, 80 and over; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Prospe | 2011 |
Anterior pituitary axis hormones and outcome in acute ischaemic stroke.
Topics: Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Epidemiologic Methods; Female; Human Growth Hor | 2011 |
Thyroid storm with multiple organ failure, disseminated intravascular coagulation, and stroke with a normal serum FT3 level.
Topics: Anti-Inflammatory Agents; Anticoagulants; Antithyroid Agents; Brain Edema; Decompression, Surgical; | 2012 |
[Determining blood parameters FT3, FT4, T, E2 and cortisol to explore nature of cold syndrome and heat syndrome].
Topics: Adolescent; Adult; Aged; Communicable Diseases; Diagnosis, Differential; Estradiol; Female; Humans; | 2002 |
Malnutrition and nonthyroidal illness syndrome after stroke.
Topics: Adult; Aged; Deglutition Disorders; Female; Humans; Male; Middle Aged; Nutritional Status; Protein-E | 2005 |
Hypothyroidism as a protective factor in acute stroke patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Chi-Square Distribution; Female; Humans; Hypothyroidism; Isc | 2006 |
Low triiodothyronine: a strong predictor of outcome in acute stroke patients.
Topics: Aged; Aged, 80 and over; Biomarkers; Euthyroid Sick Syndromes; Female; Humans; Hypothyroidism; Male; | 2007 |